{"id":2280,"company":{"country":"BM","currency":"CHF","exchange":"NASDAQ NMS - GLOBAL MARKET","ipo":"2014-08-06","marketCap":5.10431,"name":"Altamira Therapeutics Ltd","phone":"410417297194","outstanding":8.83,"symbol":"CYTO","website":"https://aurismedical.com/","industry":"Pharmaceuticals"},"price":3.7625,"year":2023,"month":12,"day":16,"weekday":"Saturday","title":"Historical Performance of Altamira Therapeutics Ltd Stock compared to Industry Benchmarks","date":"2023-12-16","url":"/posts/2023/12/16/CYTO","content":[{"section":"Introduction","text":"Altamira Therapeutics Ltd is a pharmaceutical company that specializes in the development of innovative treatments for various diseases. To assess the historical performance of the company's stock, it is important to compare it with the performance of relevant industry benchmarks. This analysis will provide insights into how Altamira Therapeutics Ltd has fared in relation to its industry peers."},{"section":"Stock Performance Overview","text":"Altamira Therapeutics Ltd stock performance can be assessed by analyzing key financial metrics, including stock price, market capitalization, and shareholder returns over a specific period. Historical stock price data can be compared to industry benchmarks to identify trends and assess relative performance."},{"section":"Comparison to Industry Benchmarks","text":"To accurately benchmark Altamira Therapeutics Ltd stock, it is important to select appropriate industry benchmarks. These benchmarks can include sector-specific indices, such as pharmaceutical or healthcare indices, or broader market indices like the S\u0026P 500. By comparing Altamira Therapeutics Ltd's stock performance to these benchmarks, it becomes possible to assess the stock's relative performance and determine if it has outperformed or underperformed the industry."},{"section":"Key Factors Influencing Performance","text":"Examining the key factors influencing Altamira Therapeutics Ltd's stock performance is crucial for a comprehensive analysis. Factors such as company announcements, clinical trial results, regulatory approvals, market conditions, and industry trends play a significant role in determining stock performance. By considering these factors, it becomes possible to understand the context behind the stock's historical performance and identify any catalysts or hindrances to its growth."},{"section":"Volatility and Risk Analysis","text":"Volatility and risk are important considerations when assessing the historical performance of Altamira Therapeutics Ltd stock. Volatility measures the magnitude of price fluctuations, while risk assesses the likelihood of future loss. Comparing these metrics to industry benchmarks helps determine if the stock's performance aligns with expected levels of risk and volatility in the industry."},{"section":"Conclusion","text":"Analyzing the historical performance of Altamira Therapeutics Ltd stock compared to industry benchmarks provides valuable insights into its relative performance within the industry. By considering key financial metrics, industry benchmarks, influencing factors, and risk analysis, a comprehensive assessment of the stock's performance can be achieved. This analysis helps investors understand the context behind the stock's historical performance and make informed investment decisions."},{"section":"","text":""},{"section":"","text":""}],"tags":["CrossOver55","Long","Pharmaceuticals"],"news":[{"category":"company","date":1702529580,"headline":"CYTO Stock Earnings: Altamira Therapeutics Reported Results for H1 2023","id":124530129,"image":"","symbol":"CYTO","publisher":"InvestorPlace","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3256593604"},{"category":"company","date":1702476063,"headline":"Altamira Therapeutics Ltd. (CYTO) Special Call Transcript","id":124490332,"image":"https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png","symbol":"CYTO","publisher":"SeekingAlpha","summary":"Altamira Therapeutics Ltd. (NASDAQ:NASDAQ:CYTO) Special Call December 11, 2023 8:30 AM ETCompany ParticipantsThomas Meyer - Founder, Chairman and...","url":"https://seekingalpha.com/article/4657740-altamira-therapeutics-ltd-cyto-special-call-transcript"},{"category":"company","date":1702457280,"headline":"Altamira Therapeutics trading resumes","id":124504555,"image":"","symbol":"CYTO","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3255047001"},{"category":"company","date":1702456980,"headline":"Altamira Therapeutics trading halted, volatility trading pause","id":124504556,"image":"","symbol":"CYTO","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3255039374"},{"category":"company","date":1702363800,"headline":"Altamira Therapeutics trading halted, news pending","id":124474132,"image":"","symbol":"CYTO","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3254152747"},{"category":"company","date":1702362780,"headline":"Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday","id":124460608,"image":"","symbol":"CYTO","publisher":"InvestorPlace","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3253111961"},{"category":"company","date":1702299600,"headline":"Altamira Therapeutics Provides Investor and Business Update","id":124445193,"image":"https://media.zenfs.com/en/globenewswire.com/7088cba5de882ce449f72f383f378db2","symbol":"CYTO","publisher":"Yahoo","summary":"HAMILTON, BERMUDA, Dec. 11, 2023 (GLOBE NEWSWIRE) -- Company hosts Investor and Business Update call on December 11 at 8:30 a.m. ETPartial spin-off of Bentrio® business first step in transition to become ‘pure play’ RNA delivery companyTransition expected to complete in 2024 through partnering of further legacy assetsSpending levels and cash burn aligned with strategic repositioning and to decrease significantly in 2024 Free of financial debt following early repayment of convertible loan Expects","url":"https://finance.yahoo.com/news/altamira-therapeutics-provides-investor-business-130000363.html"},{"category":"company","date":1702297020,"headline":"Why bluebird bio Shares Are Trading Higher? Here Are Other Stocks Moving In Monday's Mid-Day Session","id":124440107,"image":"","symbol":"CYTO","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3251695393"},{"category":"company","date":1702294560,"headline":"12 Health Care Stocks Moving In Monday's Intraday Session","id":124438974,"image":"","symbol":"CYTO","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3251636486"},{"category":"company","date":1702287000,"headline":"Altamira shares sink over 40% on corporate, stock split updates","id":124451101,"image":"","symbol":"CYTO","publisher":"Seeking Alpha","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3251462676"},{"category":"company","date":1702286820,"headline":"US Stocks Mixed; Cigna Shares Spike Higher","id":124437242,"image":"","symbol":"CYTO","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3251458910"},{"category":"company","date":1702279560,"headline":"Altamira Therapeutics to effect 20-for-1 reverse stock split","id":124451105,"image":"","symbol":"CYTO","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3251309421"},{"category":"company","date":1702279560,"headline":"Altamira says 'substantially' lowered spending levels in 2023","id":124451104,"image":"","symbol":"CYTO","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3251309417"},{"category":"company","date":1702279500,"headline":"Altamira Therapeutics to host business update conference call","id":124451107,"image":"","symbol":"CYTO","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3251308427"},{"category":"company","date":1702279500,"headline":"Altamira 'progressing' with development of OligoPhore, SemaPhore platforms","id":124451106,"image":"","symbol":"CYTO","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3251308420"},{"category":"company","date":1702279440,"headline":"Altamira Therapeutics proides update following partial Bentrio spin-off","id":124451108,"image":"","symbol":"CYTO","publisher":"Thefly.com","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3251307444"},{"category":"company","date":1701862380,"headline":"12 Health Care Stocks Moving In Wednesday's Intraday Session","id":124338947,"image":"","symbol":"CYTO","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3244316922"},{"category":"company","date":1701846540,"headline":"12 Health Care Stocks Moving In Wednesday's Pre-Market Session","id":124332434,"image":"","symbol":"CYTO","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3243963185"},{"category":"company","date":1701833760,"headline":"12 Health Care Stocks Moving In Wednesday's After-Market Session","id":124344289,"image":"","symbol":"CYTO","publisher":"Benzinga","summary":"Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.","url":"https://www.zacks.com/research/get_news.php?id=3244684972"},{"category":"company","date":1701798840,"headline":"Altamira Therapeutics to Host Investor \u0026 Business Update Call on  December 11th","id":124316710,"image":"https://media.zenfs.com/en/globenewswire.com/7088cba5de882ce449f72f383f378db2","symbol":"CYTO","publisher":"Yahoo","summary":"HAMILTON, BERMUDA , Dec. 05, 2023 (GLOBE NEWSWIRE) -- HAMILTON, BERMUDA--December 5, 2023--Altamira Therapeutics Ltd. (\"Altamira\" or the \"Company\") (Nasdaq: CYTO), a company dedicated to developing therapeutics that address important unmet medical needs, announced today that it will host an Investor and Business Update Call on Monday, December 11, 2023, 8:30 a.m. ET. The presentation will be available via teleconference or webcast with audio and presenter-controlled slides. Webcast Access: Date:","url":"https://finance.yahoo.com/news/altamira-therapeutics-host-investor-business-175400648.html"}]}